Promotion of Research and Innovation in Pharma MedTech sector (PRIP) is a grant from Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers for entities registered in India. It provides Up to ₹100 Cr, for pharma · medtech · medical devices · biologics. The current deadline is 17 November 2026.
Key facts
| Amount / benefit | Up to ₹100 Cr |
|---|---|
| Provider | Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers |
| Where | Pan-India |
| Stage | Early Revenue, Growth, Idea, Prototype |
| Sector | pharma · medtech · medical devices · biologics |
| Deadline | 17 November 2026 |
What is Promotion of Research and Innovation in Pharma MedTech sector?
Promotion of Research and Innovation in Pharma MedTech sector (PRIP) — Early stage: up to ₹1 crore fully funded, ₹1-5 crore at up to 50% of cost; NCE/NBE discovery: up to ₹50 crore (min 25% co-funded by institutional investors); later stage: up to ₹100 crore at up to 35% of cost (50% for strategic priority innovations) — Entities registered in India. Early-stage (TRL 1-3 completed) and NCE/NBE discovery tracks are open to DPIIT-recognised startups and Udyam-registered MSMEs only; the later-stage track (TRL 4-6) is open to industry, startups and MSMEs. Priority areas: new medicines, complex generics and biosimilars, novel medical devices. It is run by Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
The support is delivered through the programme’s own structure, and the form it takes is set by the issuing authority. The amount and form of support that actually apply to you depend on the programme’s rules and how your application is assessed — they are not fixed for every applicant.
It is aimed at businesses in pharma · medtech · medical devices · biologics. Like most government programmes, it has its own eligibility conditions, documentation and application window, and these terms are revised from time to time. Because of that, it is worth confirming the current eligibility, amount and deadline on the official programme page before you invest time in applying.
Who is eligible for Promotion of Research and Innovation in Pharma MedTech sector?
Entities registered in India. Early-stage (TRL 1-3 completed) and NCE/NBE discovery tracks are open to DPIIT-recognised startups and Udyam-registered MSMEs only; the later-stage track (TRL 4-6) is open to industry, startups and MSMEs. Priority areas: new medicines, complex generics and biosimilars, novel medical devices. Not for: Early-stage and NCE/NBE tracks exclude large companies. Applicants disqualified under section 3.3 of the guidelines (eligibility conditions) cannot apply..
How much does Promotion of Research and Innovation in Pharma MedTech sector give, and in what form?
Up to ₹100 Cr.
Frequently asked questions
Who runs this programme?
Promotion of Research and Innovation in Pharma MedTech sector (PRIP) is offered by Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. Eligibility and approval rest with them; the criteria and amounts are set by the programme.
Is there a deadline to apply?
The programme lists a deadline of 2026-11-17. Government timelines can change, so confirm the current date on the official programme page before you apply.
How do I know if I’m eligible?
Read “Who can apply” above for the programme’s own criteria. If you’d like a quick read on your specific case, our free 2-minute eligibility check maps your stage, sector and revenue to what you can realistically claim.
Related programmes
Browse similar grant programmes. CapEasy handles this under Fundraising advisory. CapEasy handles this under Startup India and DPIIT recognition.
Source and verification
No official page is linked for this programme yet. Verification date pending. Government programmes change — confirm current eligibility, amounts and deadlines on the official programme page before you apply. CapEasy is a private consultancy and is not affiliated with any government authority.